Do you still think Gilead Sciences, Inc (NASDAQ:GILD) is worth a look?

Stocks of Gilead Sciences, Inc (NASDAQ:GILD) traded higher last session on Wall Street, up 0.26% to $97.20. GILD stock price is now 5.51% away from the 50-day moving average and 21.99% away from the 200-day moving average. The market capitalization of the company currently stands at $121.14B. With the price target enhanced from $87 to […]

Nike, Inc (NKE) Price Aside, NKE Fundamentals Booming Beyond Compare

The price of Nike, Inc (NYSE:NKE) shares last traded on Wall Street fell -1.83% to $76.90. NKE stock price is now 1.69% away from the 50-day moving average and -6.04% away from the 200-day moving average. The market capitalization of the company currently stands at $113.75B. With the price target enhanced from $72 to $90, […]

Reasons why Viasat, Inc’s (NASDAQ:VSAT) fundamentals are futile

In yesterday’s Wall Street session, Viasat, Inc (NASDAQ:VSAT) shares traded at $9.24, down -2.48% from the previous session. VSAT stock price is now 1.23% away from the 50-day moving average and -30.65% away from the 200-day moving average. The market capitalization of the company currently stands at $1.19B. With the price target of $12, Cantor […]

Despite Novavax, Inc [NVAX]’s great opportunity, the stock is a bit overvalued

The price of Novavax, Inc (NASDAQ:NVAX) shares last traded on Wall Street rose 2.27% to $9.01. NVAX stock price is now 3.01% away from the 50-day moving average and -18.29% away from the 200-day moving average. The market capitalization of the company currently stands at $1.44B. With the price target maintained at $8, JP Morgan […]

Do you still think Cardinal Health, Inc (NYSE:CAH) is worth a look?

Stocks of Cardinal Health, Inc (NYSE:CAH) traded higher last session on Wall Street, up 0.39% to $128.26. CAH stock price is now 5.25% away from the 50-day moving average and 17.31% away from the 200-day moving average. The market capitalization of the company currently stands at $31.04B. With the price target enhanced from $130 to […]

Does Gilead Sciences, Inc (NASDAQ:GILD) have deteriorating prospects?

Gilead Sciences, Inc (NASDAQ:GILD) shares traded 1.85% higher at $95.59 on Wall Street last session. GILD stock price is now 4.07% away from the 50-day moving average and 20.41% away from the 200-day moving average. The market capitalization of the company currently stands at $119.13B. With the price target enhanced from $87 to $113, Morgan […]

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.